Fig. 4From: A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic targetIndirect IF micrograph demonstrating the co-localisation (yellow) of TrkAIII (green) and γtubulin (red) in a stage IV, MCPyV positive (MCPyV+) MCC (Patient, P.1 (i)) (bar = 50 μm)Back to article page